These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34228017)

  • 21. Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial.
    Evans SR; Knutsson M; Amarenco P; Albers GW; Bath PM; Denison H; Ladenvall P; Jonasson J; Easton JD; Minematsu K; Molina CA; Wang Y; Wong KL; Johnston SC
    Clin Trials; 2020 Dec; 17(6):617-626. PubMed ID: 32666831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
    Kubo Y; Sterling LR; Parfrey PS; Gill K; Mahaffey KW; Gioni I; Trotman ML; Dehmel B; Chertow GM
    Pharm Stat; 2015; 14(3):242-51. PubMed ID: 25851955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives.
    Beckett RD; Loeser KC; Bowman KR; Towne TG
    BMC Med Res Methodol; 2016 Aug; 16(1):106. PubMed ID: 27557676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organising Support for Carers of Stroke Survivors (OSCARSS): study protocol for a cluster randomised controlled trial, including health economic analysis.
    Patchwood E; Rothwell K; Rhodes S; Batistatou E; Woodward-Nutt K; Lau YS; Grande G; Ewing G; Bowen A
    Trials; 2019 Jan; 20(1):19. PubMed ID: 30616692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized Pragmatic Trial of Stroke Transitional Care: The COMPASS Study.
    Duncan PW; Bushnell CD; Jones SB; Psioda MA; Gesell SB; D'Agostino RB; Sissine ME; Coleman SW; Johnson AM; Barton-Percival BF; Prvu-Bettger J; Calhoun AG; Cummings DM; Freburger JK; Halladay JR; Kucharska-Newton AM; Lundy-Lamm G; Lutz BJ; Mettam LH; Pastva AM; Xenakis JG; Ambrosius WT; Radman MD; Vetter B; Rosamond WD;
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006285. PubMed ID: 32475159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methodological considerations in the design of the WHO Antenatal Care Randomised Controlled Trial.
    Donner A; Piaggio G; Villar J; Pinol A; al-Mazrou Y; Ba'aqeel H; Bakketeig L; Belizán JM; Berendes H; Carroli G; Farnot U; Lumbiganon P
    Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():59-74. PubMed ID: 9805723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interval-cohort designs and bias in the estimation of per-protocol effects: a simulation study.
    Young JG; Vatsa R; Murray EJ; Hernán MA
    Trials; 2019 Sep; 20(1):552. PubMed ID: 31488202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale and methods of an Evaluation of the Effectiveness of the Community Paramedicine at Home (CP@home) program for frequent users of emergency medical services in multiple Ontario regions: a study protocol for a randomized controlled trial.
    Agarwal G; Pirrie M; McLeod B; Angeles R; Tavares W; Marzanek F; Thabane L
    Trials; 2019 Jan; 20(1):75. PubMed ID: 30674347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and inference for the intent-to-treat principle using adaptive treatment.
    Dawson R; Lavori PW
    Stat Med; 2015 Apr; 34(9):1441-53. PubMed ID: 25581413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methodological challenges in pragmatic trials in Alzheimer's disease and related dementias: Opportunities for improvement.
    Taljaard M; Li F; Qin B; Cui C; Zhang L; Nicholls SG; Carroll K; Mitchell SL
    Clin Trials; 2022 Feb; 19(1):86-96. PubMed ID: 34841910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cluster randomized trial in the general practice research database: 2. Secondary prevention after first stroke (eCRT study): study protocol for a randomized controlled trial.
    Dregan A; van Staa T; McDermott L; McCann G; Ashworth M; Charlton J; Wolfe C; Rudd A; Yardley L; Gulliford M;
    Trials; 2012 Oct; 13():181. PubMed ID: 23034059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the Estimand Framework to Manage the Disruptive Effects of COVID-19 on Stroke Clinical Trials.
    Yassi N; Hayward KS; Campbell BCV; Churilov L
    Stroke; 2021 Nov; 52(11):3739-3747. PubMed ID: 34587797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity in pragmatic randomised trials: sources and management.
    Giraudeau B; Caille A; Eldridge SM; Weijer C; Zwarenstein M; Taljaard M
    BMC Med; 2022 Oct; 20(1):372. PubMed ID: 36303153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrasting approaches for addressing non-adherence in randomized controlled trials: An illustration from the REFLUX trial.
    Keele L; Grieve R
    Clin Trials; 2022 Feb; 19(1):97-106. PubMed ID: 34949104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke.
    Winkel P; Bath PM; Gluud C; Lindschou J; van der Worp HB; Macleod MR; Szabo I; Durand-Zaleski I; Schwab S;
    Trials; 2017 Nov; 18(1):573. PubMed ID: 29187242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skilled Nursing and Inpatient Rehabilitation Facility Use by Medicare Fee-for-Service Beneficiaries Discharged Home After a Stroke: Findings From the COMPASS Trial.
    Freburger JK; Pastva AM; Coleman SW; Peter KM; Kucharska-Newton AM; Johnson AM; Psioda MA; Duncan PW; Bushnell CD; Rosamond WD; Jones SB;
    Arch Phys Med Rehabil; 2022 May; 103(5):882-890.e2. PubMed ID: 34740596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample size calculation for randomized trials via inverse probability of response weighting when outcome data are missing at random.
    Harrison LJ; Wang R
    Stat Med; 2023 May; 42(11):1802-1821. PubMed ID: 36880120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Per-Protocol analyses produced larger treatment effect sizes than intention to treat: a meta-epidemiological study.
    Mostazir M; Taylor G; Henley WE; Watkins ER; Taylor RS
    J Clin Epidemiol; 2021 Oct; 138():12-21. PubMed ID: 34161805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): study protocol for a randomised, stepped-wedge cluster trial within the EFFECTS trial.
    Lundström E; Isaksson E; Wester P; Laska AC; Näsman P
    Trials; 2018 Jan; 19(1):14. PubMed ID: 29310679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inconsistent definitions for intention-to-treat in relation to missing outcome data: systematic review of the methods literature.
    Alshurafa M; Briel M; Akl EA; Haines T; Moayyedi P; Gentles SJ; Rios L; Tran C; Bhatnagar N; Lamontagne F; Walter SD; Guyatt GH
    PLoS One; 2012; 7(11):e49163. PubMed ID: 23166608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.